Review of Cardiometabolic Effects of Prescription Omega-3 Fatty Acids - PubMed

Clinical trial evidence supports use of n-3FAs in individuals with established atherosclerotic cardiovascular disease (ASCVD), but the data either does not support or is lacking for other types of cardiometabolic risk including prevention of stroke, treatment in patients with heart failure, diabetes …分類：pmid:29116404, doi:10.1007/s11883-017-0700-z, Review, Megan F Burke, Frances M Burke, Daniel E Soffer, Cardiovascular Diseases / drug therapy*, Dietary Supplements, Fatty Acids, Omega-3 / therapeutic use*, Humans, Metabolic Diseases / drug therapy*, PubMed Abstract, NIH, NLM, NCBI, National Institutes of Health, National Center for Biotechnology Information, National Library of Medicine, MEDLINE...